Hall-Riggs syndrome

Hall-Riggs syndrome (also known as Hall-Riggs mental retardation syndrome) is an extremely rare autosomal recessive disorder characterized by the combination of intellectual disability, skeletal abnormalities, and distinctive facial features. The condition was first described by Hall and Riggs in 1975 and affects multiple body systems, most notably the skeletal system and central nervous system. Key clinical features include moderate to severe intellectual disability, short stature, and spondylometaphyseal dysplasia (abnormalities of the vertebrae and the growing ends of long bones). Affected individuals typically present with microcephaly (abnormally small head), a flat midface, depressed nasal bridge, and epicanthal folds. Skeletal manifestations include platyspondyly (flattened vertebral bodies), metaphyseal irregularities of the long bones, and delayed bone age. Some patients may also exhibit seizures and hypotonia (decreased muscle tone). The onset of recognizable features is typically in infancy or early childhood, as developmental delays and skeletal abnormalities become apparent. There is currently no specific or curative treatment for Hall-Riggs syndrome. Management is supportive and symptomatic, involving multidisciplinary care including developmental support, physical therapy, orthopedic monitoring for skeletal complications, and neurological management for seizures when present. The genetic basis of this condition remains incompletely characterized, and only a very small number of cases have been reported in the medical literature.

Common questions about Hall-Riggs syndrome